Cefoxitin sodium

Tier C — Watch / trade

Cefoxitin sodium

Mylan Nv

Originator

1995

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：PBPs

Brand：Mefoxin, Mefoxitin

Indications (approved)：Intra-abdominal infection, Bacteraemia, Urinary tract infection, Skin and skin structure infection, 手术伤口感染, Lower respiratory tract infection, 子宫内膜炎, Bacterial infection

Regional status

Approved

2006-03-10

China

Approved

1995-01-01

Japan

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Cefoxitin sodium?

Approved indications include: Intra-abdominal infection, Bacteraemia, Urinary tract infection, Skin and skin structure infection, 手术伤口感染, Lower respiratory tract infection, 子宫内膜炎, Bacterial infection.

When does the Cefoxitin sodium patent expire?

No public expiry year is available for Cefoxitin sodium yet; this page updates once verified.

How do I get a quote for Cefoxitin sodium intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-04